SecBot SecBot
SECBOTREPLAY Home › Report › PVLA

PVLA · Palvella Therapeutics appointed John Doux, M.D., to its Board of…

PALVELLA THERAPEUTICS, INC. · 8-K filed Apr 13, 2026 at 07:30 ET

At the news

NEUTRALIMPACT 3/10

8-K filed Apr 13, 2026 at 07:30 ET

Palvella Therapeutics appointed John Doux, M.D., to its Board of Directors as a Class III member, effective April 13, 2026. Dr. Doux brings extensive experience in dermatology, biotech investing, and corporate governance from prior board roles in healthcare companies.

  • John Doux, M.D., was appointed to the Board of Directors effective April 13, 2026
  • Board size increased from six to seven members
  • Dr. Doux is a board-certified dermatologist and healthcare investor at Palo Alto Investors LP
  • He previously served on Palvella's board from 2019 to 2022 prior to its reverse merger

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access